Evaluation of Pharmacological properties, Phytochemistry and Medicinal uses of Vernoniastrum ambiguum
Alfred Maroyi
Department of Biodiversity, University of Limpopo, Private Bag X1106, Sovenga 0727, South Africa.
*Corresponding Author E-mail: alfred.maroyi@gmail.com
ABSTRACT:
Vernoniastrum ambiguum is a herbaceous plant used as traditional medicine in tropical Africa. This study was aimed at providing a critical review of the pharmacological properties, phytochemistry and medicinal uses of V. ambiguum. Documented information on the pharmacological properties, phytochemistry and medicinal uses of V. ambiguum was collected from several online sources such as Scopus, Google Scholar, PubMed and Science Direct, and pre-electronic sources such as book chapters, books, journal articles and scientific publications obtained from the University library. This study showed that the leaves, roots and whole plant parts of V. ambiguum are used as traditional medicines for dysmenorrhoea, gonorrhoea, impotence, postpartum pains, colds, female and male infertility, malaria, fever and cough. Phytochemical compounds identified from the species include glaucolide sesquiterpenes, alkaloids, amino acids, anthraquinones, cardiac glycosides, flavonoids, phenols, saponins, steroids, tannins and triterpenes. Pharmacological research revealed that V. ambiguum extracts and compounds isolated from the species have antibacterial, antifungal, anti-quorum sensing inhibition, antioxidant, antiplasmodial and hepatoprotective activities. Vernoniastrum ambiguum should be subjected to detailed phytochemical, pharmacological and toxicological evaluations aimed at correlating its medicinal uses with its phytochemistry and pharmacological properties.
KEYWORDS: Asteraceae, Compositae, ethnopharmacology, herbal medicine, indigenous pharmacopeia, Vernonia ambigua, Vernoniastrum ambiguum.
INTRODUCTION:
Vernoniastrum ambiguum (Kotschy and Peyr.) H. Rob. is a herbaceous plant belonging to the Asteraceae or Compositae family. This species was originally treated under the genus Vernonia Schreb.,1 a genus that is now known to be restricted to North America.2 The study by Isawumi1 showed that the genus Vernonia is paraphyletic and Robinson3 split this genus into several satellite genera including Vernoniastrum H. Rob. based on morphological characters.4,5 The genus Vernoniastrum consists of 12 species which are mainly annual or perennial herbs ranging in height from 0.3 to 1.0 metres that have been recorded in east, west, central and southern Africa.6 Synonyms of V. ambiguum include Cacalia ambigua Kuntze and Vernonia ambigua Kotschy and Peyr.
Vernoniastrum ambiguum is an annual herb growing up to a height of 0.3 metres.7 The stems of V. ambiguum are erect, pubescent with long spreading crispate simple hairs. The leaves are sessile with long hairs, crowded, oblanceolate in shape with apiculate to obtuse apex. The flowers are violet to white in colour on solitary or a few terminal or axillary capitula. The fruit is a tiny dry nutlet achene with white hairs at one end. Vernoniastrum ambiguum has been recorded in deciduous woodland and disturbed habitats in Angola, Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Côte d’Ivoire, the Democratic Republic of Congo (DRC), Ethiopia, Guinea, Guinea-Bissau, Liberia, Mali, Nigeria, Senegal, Sierra Leone, South Sudan, Sudan, Tanzania, Togo, Uganda and Zambia at an altitude ranging from 1300 m to 1700 m above sea level.7 Vernoniastrum ambiguum is categorized as a weed, growing along roadsides or on farmland in Kenya, Nigeria, Tanzania and Zanzibar, and the species is also used as traditional medicine in these countries.8,9 Vernoniastrum ambiguum is also collected as a leafy vegetable in Benin.10 Vernoniastrum ambiguum is categorized as an important fodder for goats and sheep in Cameroon11 and an important nectariferous plant species in Nigeria.12 Some researchers including Chinwe9 and Aworinde et al.13 argue that V. ambiguum is difficult to differentiate from other Asteraceae species such as Cyanthillium cinereum (L.) H. Rob., Gymnanthemum amygdalinum (Delile) Sch. Bip. ex Walp. and G. glaberrimum (Welw. ex O. Hoffm.) H. Rob. These authors argued that anatomical characters such as features of the midrib, petiole and epidermal strip can be used as additional taxonomical characters to differentiate the species. It is therefore, within this background that the current study was undertaken aimed at documenting the pharmacological properties, phytochemistry and medicinal uses of V. ambiguum.
MATERIAL AND METHODS:
Results of the current study are based on literature search on phytochemistry, pharmacological properties and medicinal uses of V. ambiguum using information derived from several internet databases. The databases included Scopus, Google Scholar, PubMed and Science Direct. Other sources of information such as pre-electronic sources which included journal articles, theses, books, book chapters and other scientific articles were gathered from the University library.
RESULTS AND DISCUSSION:
Medicinal uses of Vernoniastrum ambiguum:
The leaves, roots and whole plant parts of V. ambiguum are used as traditional medicines for dysmenorrhoea, gonorrhoea, impotence, postpartum pains, colds, female and male infertility, malaria, fever and cough (Table 1, Figure 1). In Cameroon, the leaves of V. ambiguum are mixed with those of Emilia coccinea (Sims) G. Don and Solanecio biafrae (Oliv. and Hiern) C. Jeffrey, and taken orally in Raphia hookeri G. Mann and H. Wendl. wine as traditional medicine for dysmenorrhoea, female or male infertility, gonorrhoea, impotence and postpartum pains.14-17 In Cameroon, the leaves of V. ambiguum are mixed with those of Aspilia africana (Pers.) C.D. Adams, Blumea heudelotii (C. D. Adams) Lisowski, Rotala stagnina Hiern, Spathodea campanulata P. Beauv. and Tapinanthus bangwensis (Engl. and K. Krause) Danser as traditional medicine for epilepsy.18
Figure 1: Medicinal applications of Vernoniastrum ambiguum derived from literature records
Table 1: Medicinal uses of Vernoniastrum ambiguum
|
Medicinal use |
Parts used |
Country |
References |
|
Cancer |
Leaf decoction taken orally |
Angola |
[19] |
|
Colds |
Root decoction taken orally |
Tanzania |
[15,20-22] |
|
Cough |
Root decoction taken orally |
Nigeria and Tanzania |
[15,16,20-25] |
|
Dysmenorrhoea |
Leaves mixed with those of Emilia coccinea (Sims) G. Don and Solanecio biafrae (Oliv. and Hiern) C. Jeffrey, and taken orally in Raphia hookeri G. Mann and H. Wendl. wine |
Cameroon |
[14,15] |
|
Epilepsy |
Leaves mixed with those of Aspilia africana (Pers.) C.D. Adams, Blumea heudelotii (C. D. Adams) Lisowski, Rotala stagnina Hiern, Spathodea campanulata P. Beauv. and Tapinanthus bangwensis (Engl. and K. Krause) Danser |
Cameroon |
[18] |
|
Female or male infertility |
Leaves mixed with those of E. coccinea and S. biafrae, and taken orally in R. hookeri wine |
Cameroon |
[14-17] |
|
Fever |
Root infusion or decoction taken orally |
Nigeria and Tanzania |
[16,20,23-25] |
|
Gonorrhoea |
Leaves mixed with those of E. coccinea and S. biafrae, and taken orally in R. hookeri wine |
Cameroon |
[14,15] |
|
Impotence |
Leaves mixed with those of E. coccinea and S. biafrae, and taken orally in R. hookeri wine |
Cameroon |
[14,15] |
|
Inflammation of uterus |
Leaf infusion or decoction taken orally |
Cameroon |
[17] |
|
Malaria |
Whole plant parts infusion or decoction taken orally |
Nigeria |
[15,16,21,22,24] |
|
Ovarian and uterus cysts |
Leaf infusion or decoction taken orally |
Cameroon |
[17] |
|
Postpartum pains |
Leaves mixed with those of E. coccinea and S. biafrae, and taken orally in R. hookeri wine |
Cameroon |
[14,15] |
|
Vaginal cleaning |
Leaf macerate applied topically |
Cameroon |
[17] |
|
Venereal diseases |
Leaf infusion or decoction taken orally |
Cameroon |
[17] |
Phytochemistry of Vernoniastrum ambiguum:
Aliyu24 identified glaucolide sesquiterpene compound 5,6-dehydrobrachycalyxolide, and other compounds such as lupeol, lupeol acetate and chrysoeriol from the leaves of V. ambiguum. Other phytochemical compounds identified from the aerial parts, leaves, seeds and whole plant parts of V. ambiguum include alkaloids, amino acids, anthraquinones, cardiac glycosides, fats, flavonoids, oils, phenols, reducing sugars, saponins, sterols, steroids, tannins, terpenes and triterpenes.16,22,23,26-30 Other researchers, see Table 2, quantified the heavy metals, mineral elements, nutritional and proximate properties of the aerial parts, leaves and whole plant parts of V. ambiguum as these may be of interest in product development and quality control. Previous research revealed that some of these phytochemical compounds may be responsible for the biological activities of the species.31-40
Table 2: Heavy metals, mineral elements, nutritional and proximate properties of Vernoniastrum ambiguum
|
Compounds, elements and proximate components |
Values |
Plant parts |
References |
|
1,1-Diethoxy-3-methylbutane (%) |
15.6 |
Leaves |
[29] |
|
3,7,11,15-Tetramethyl-2-hexadacen-1-ol (%) |
10.3 |
Leaves |
[29] |
|
Acid-insoluble ash (%) |
2.4 – 3.2 |
Aerial parts and whole plant |
[23,26] |
|
Alcohol-soluble extractive (%) |
3.7 - 5.5 |
Aerial parts and whole plant |
[23,26] |
|
Cadmium (mg/100 g/dry weight) |
0.009 |
Leaves |
[42] |
|
Calcium (mg/100 g/dry weight) |
89.0 |
Leaves |
[42] |
|
Caryophyllene oxide (%) |
6.5 |
Leaves |
[29] |
|
Chromium (mg/100 g/dry weight) |
0.6 |
Leaves |
[42] |
|
Cobalt (mg/100 g/dry weight) |
0.3 |
Leaves |
[42] |
|
Copper (mg/100 g/dry weight) |
0.3 |
Leaves |
[42] |
|
Hexadecanoic acid (%) |
13.3 |
Leaves |
[29] |
|
Iron (mg/100 g/dry weight) |
21.9 |
Leaves |
[42] |
|
Isoamylacetate (%) |
6.5 |
Leaves |
[29] |
|
Lead (mg/100 g/dry weight) |
0.05 |
Leaves |
[42] |
|
Linoleic acid (%) |
10.2 |
Leaves |
[29] |
|
Linolenic acid (%) |
12.0 |
Leaves |
[29] |
|
Magnesium (mg/100 g/dry weight) |
8.7 |
Leaves |
[42] |
|
Manganese (mg/100 g/dry weight) |
2.0 |
Leaves |
[42] |
|
Moisture content (%) |
8.2 – 8.8 |
Aerial parts and whole plant |
[23,26] |
|
Phytol (%) |
10.8 |
Leaves |
[29] |
|
Total ash (%) |
13.8 - 13.9 |
Aerial parts and whole plant |
[23,26] |
|
Water-soluble extractive (%) |
20.1 - 20.6 |
Aerial parts and whole plant |
[23,26] |
|
Zinc (mg/100 g/dry weight) |
0.4 |
Leaves |
[42] |
Pharmacological properties of Vernoniastrum ambiguum:
The following biological activities have been reported from the aerial parts, leaves, roots and whole plant parts of V. ambiguum: antibacterial,25-27,43 antifungal,26,28,29 anti-quorum sensing inhibition,24 antioxidant,16,22 antiplasmodial16,22 and hepatoprotective44 activities.
Antibacterial activities:
Kunle et al.26 evaluated the antibacterial activities of methanol extracts of aerial parts of V. ambiguum against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium, Klebsiella pneumoniae, Streptococcus pyogenes, Streptococcus faecalis, Corynebacterium ulcerans, Listeria monocytogenes, Bacillus cereus, Klebsialla ozaenae, Proteus mirabilis, Proteus vulgaris, Pseudomonas flourescense and Shigella dysenteriae using disc diffusion and broth dilution methods with sparfloxacin (0.2mg/ml) and erythromycin (0.5mg/ml) as positive controls. The extract exhibited activities against the tested pathogens with zone of inhibition ranging from 15.0mm to 24.0mm. The minimum inhibitory concentration (MIC) values ranged from 2.5mg/ml to 5.0mg/ml while the minimum bactericidal concentration (MBC) value was 10.0mg/ml.26 Aliyu et al.27 evaluated the antibacterial activities of ethanol and chloroform extracts of aerial parts of V. ambiguum against Klebsiella pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, Corynbacterium ulcerans, methicillin resistant Staphylococcus aureus (MRSA), Salmonella typhi, Pseudomonas aeruginosa, Shigella dysentriae, Proteus mirabilis and Pseudomonas fluorescence using disc diffusion and micro-broth dilution methods with ampiclox (75.0µg/dics) and streptomycin (30.0µg/dics) as positive controls. The extracts exhibited activities against most pathogens with the exception of Shigella dysentriae, Proteus mirabilis and Pseudomonas fluorescence with the zone of inhibition ranging from 14.0mm to 22.0mm in comparison to 20.0mm to 27.0 mm exhibited by the positive controls. The MIC values ranged from 1.3mg/mL to 2.5mg/mL.27 Akinwande et al.43 evaluated the efficacy of supplementing diet with the ethanolic extract of V. ambiguum leaves on the innate immune response in Heterobranchus longifilis (African catfish) and resistance to bacterial species Pseudomonas aeruginosa. Feeding Heterobranchus longifilis with 5.0% of 100g/kg of feed daily for a period of 42 days resulted in enhancing the blood leukocyte phagocytic and increased leukocytes respiratory burst activities. While bacterial mortalities recorded following 42 days of supplementary feeding with the extract resulted in 44.0% relative percent survival.43 Okafo et al.25 evaluated the antibacterial activities of ethanol extract of the leaves of V. ambiguum against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa using the disc diffusion method with gentamicin as a positive control. The extract exhibited weak activities against tested pathogens with zone of inhibition ranging from 2.0mm to 10.0mm in comparison to 28.5mm to 36.0mm exhibited by the positive control.25
Antifungal activities:
Kunle et al.26 evaluated the antifungal activities of methanol extracts of aerial parts of V. ambiguum against Aspergillus fumigates, Candida albicans, Microsporum gypseum and Trichophyton rubrum using disc diffusion and broth dilution methods with flouconazole (0.5 mg/ml) as a positive control. The extract exhibited activities against Candida albicans with the zone of inhibition, MIC and minimum fungicidal concentration (MFC) values of 17.0mm, 5.0mg/ml and 10.0mg/ml, respectively.26 Ilondu28 evaluated the antifungal activities of ethanolic extract of V. ambiguum leaves against Sclerotium roltsii at the concentrations of 100.0 mg/ml, 80.0mg/ml. 60.0mg/ml, 40.0mg/ml and 20.0 mg/ml using the disc diffusion assay. The extract exhibited dose-dependent activities against the pathogen, causing 100% inhibition at 80mg/ml while at 60.0 mg/ml, the extract inhibited the Sclerotium roltsii germination.28 Ilondu29 evaluated the antifungal activities of the ethanolic extracts of the V. ambiguum leaves against Cercosporella persica and Curvularia lunatus isolates of groundnut leafspot disease at the concentrations of 100, 200, 300, 400 and 500mg/mL tested on potato dextrose agar medium with dithane M-45 as a positive control. The maximum growth inhibition of Cercosporella persica was observed at 200.0mg/mL and 300.0mg/mL for Curvularia lunatus.29
Anti-quorum sensing inhibition:
Aliyu24 evaluated the anti-quorum sensing inhibition activities of the crude extracts of V. ambiguum leaves and the compounds lupeol, lupeol acetate and 5,6-dehydrobrachycalyxolide isolated from the leaves of the species using the violacein inhibition assay. The crude extract and all the compounds exhibited activities with inhibition ≥84.0% at a concentration of 2.6mg/mL.24
Antioxidant activities:
Builders et al.16 evaluated the antioxidant activities of the aqueous extracts of V. ambiguum whole plant parts using 2,2’-diphenyl-1 picryl-hydrazyl (DPPH) free radical scavenging assay with ascorbic acid as a standard drug. The extract exhibited moderate antioxidant activities.16 Builders22 evaluated the antioxidant activities of the aqueous extracts of V. ambiguum whole plant parts using the DPPH free radical scavenging assay with ascorbic acid as a standard drug. The extract exhibited concentration dependent activities with percentage inhibition ranging from 70.0% to 80.0%.22
Antiplasmodial activities:
Builders et al.16 evaluated in vivo antiplasmodial activities of aqueous extracts of V. ambiguum whole plant parts assessed using four days suppressive, curative and prophylactic effects in Swiss albino mice at doses of 50.0, 100.0, 200.0, 300.0, 400.0, 500.0 and 600.0mg/kg po body weight administered with Plasmodium berghei and chloroquine as a positive control. The extracts exhibited dose dependent inhibitions of parasitaemia of 56.9%, 57.7%, 63.0% in suppressive, curative and prophylactic tests, respectively at a dose of 600.0mg/kg po. Builders et al.16 also evaluated in vitro antiplasmodial activities of aqueous extracts of V. ambiguum whole plant parts against Plasmodium falciparum using the in vitro micro test. The in vitro screening exhibited moderate activities with half maximal inhibitory concentration (IC50) value of 31.6 μg/mL.16 Builders22 evaluated in vivo antiplasmodial activities of aqueous extracts of V. ambiguum whole plant parts assessed using four days suppressive, curative and prophylactic effects in Swiss albino mice at doses of 200.0, 400.0 and 600.0mg/kg po body weight administered with Plasmodium berghei and chloroquine as a positive control. The extracts exhibited dose dependent inhibitions of parasitaemia in suppressive, curative and prophylactic tests. Builders22 also evaluated in vitro antiplasmodial activities of aqueous extracts of V. ambiguum whole plant parts against Plasmodium falciparum using the in vitro micro test. The in vitro screening exhibited moderate activities with IC50 value of 31.6μg/mL.22
Hepatoprotective activity:
Orji et al.44 evaluated the hepatoprotective activities of the ethanol extract of V. ambiguum leaves using the carbon tetrachloride (CCl4)-induced hepatotoxicity model to assess the effect of the extract on liver damage in wistar albino rats with silymarin as a positive control. The extract exhibited dose-dependent activities causing a decrease in the liver marker enzymes, bilirubin, total cholesterol and triacylglycerols.44
CONCLUSION:
The present review summarizes the medicinal uses, phytochemistry and pharmacological properties of V. ambiguum. Although V. ambiguum has been the subject of phytochemical and pharmacological research for several years, there is not yet enough data correlating the ethnomedicinal uses of the species with its phytochemical and pharmacological properties. Detailed studies on the pharmacokinetics, in vivo and clinical research involving both extracts and compounds isolated from the species are required. Therefore, future research should focus on the molecular modes or mechanisms of action, pharmacokinetics and physiological pathways for specific extracts of the species including identification of the bioactive compounds of the species and their associated pharmacological activities.
REFERENCES:
1. Isawumi MA. Infrageneric classification of Vernonia (Vernonieae: Compositae) in West Africa. In Hind DJN, Beentje HJ (Editor), Compositae: systematics. Proceedings of the International Compositae Conference. Royal Botanic Gardens, Kew, London, UK. 1996; pp. 531-544.
2. Robinson H, Skvarla JJ, Funk VA. Vernonieae (Asteraceae) of southern Africa: A generic disposition of the species and a study of their pollen. PhytoKeys. 2016; 60: 49–126.
3. Robinson H. Generic and subtribal classification of American Vernonieae. Smithsonian Contributions to Botany. 1999; 89: 1–116.
4. Robinson H. The status of generic and subtribal revisions in the Vernonieae. In Hind DJN, Beentje HJ (Editor), Compositae: systematics. Proceedings of the International Compositae Conference. Royal Botanic Gardens, Kew, London, UK. 1996; pp. 511-529.
5. Robinson H. Tribe Vernonieae Cass. In Kadereit JW, Jeffrey C (Editor), The families and genera of vascular plants: Flowering plants: Eudicots, Asterales. Springer, Berlin, Germany. 2007; pp. 149-174.
6. Isawumi MA. The status of generic revision in the African Vernonieae (Asteraceae). Compositae Newsletter. 2008; 46: 27-48.
7. Beentje HJ, Jeffrey C, Hind DJN. Compositae: Part 3. Flora of tropical East Africa. Kew, Royal Botanic Gardens, London, UK. 2005.
8. Makokha DW, Irakiza R, Malombe I, Le Bourgeois T, Rodenburg J. Dualistic roles and management of non-cultivated plants in lowland rice systems of East Africa. South African Journal of Botany. 2017; 108: 321–330.
9. Chinwe UA. Anatomical studies of the midrib, petiole and epidermal strip of some Vernonia species, from Nigeria. International Journal of Botany 2020. 16: 9-19.
10. Achigan–Dako EG, Ndanikou S. Diversity of traditional vegetables and local taxonomy. In Achigan–Dako EG, Pasquini MW, Assogba Komlan F, Ndanikou S, Dansi A, Ambrose–Oji B. Traditional vegetables in Benin: Diversity, distribution, ecology, agronomy and utilization. Institut National des Recherches Agricoles du Bénin. Imprimeries du CENAP, Cotonou, Benin. 2010; pp. 20-47.
11. Lucha CF, Chuyong GB. Ethnobotanical survey of fodder/forage plant species in range and farming systems in the savannahs of Ngoketunjia, north western Cameroon. International Journal of Current Research in Biosciences and Plant Biology. 2016; 3(6): 50-72.
12. Akunne CE, Akpan AU, Ononye BU. Pattern of nectariferous plant diversity of African honeybee (Apis mellifera adansonii L.) in Awka and Agulu environs, southeast Nigeria. Journal of Apiculture 2016; 31(4): 281-291.
13. Aworinde DO, Ogundairo BO, Erinoso SM. Comparative leaf architectural studies of some Vernonia Schreb (Asteraceae) in Nigeria. Current Botany. 2013; 4(3): 43-47.
14. Focho DA, Nkeng EAP, Lucha CF, Ndam WT, Afegenui A. Ethnobotanical survey of plants used to treat diseases of the reproductive system and preliminary phytochemical screening of some species of Malvaceae in Ndop central sub-division, Cameroon. Journal of Medicinal Plants Research. 2009; 3: 301–314.
15. Toyang NJ, Verpoorte R. A review of the medicinal potentials of plants of the genus Vernonia (Asteraceae). Journal of Ethnopharmacology. 2013; 146: 681–723.
16. Builders MINN, Ajoku GA, Builders PF, Orisadipe A, Aguiyi JC. Evaluation of the antimalarial potential of Vernonia ambigua Kotschy and Peyr (Asteraceae). International Journal of Pharmacology. 2011; 7: 238–247.
17. Tsobou R, Mapongmetsem PM, Van Damme P. Medicinal plants used for treating reproductive health care problems in Cameroon, central Africa. Economic Botany. 2016; 70(2): 145–159.
18. Noumi E, Fozi FL. Ethnomedical botany of epilepsy treatment in Fongo-Tongo village, western province, Cameroon. Pharmaceutical Biology. 2003; 41(5): 330-339.
19. Colditz GA. The SAGE encyclopedia of cancer and society. SAGE Publications, California, USA; 2015.
20. Burkill HM. The useful plants of west tropical Africa. Royal Botanic Gardens Kew, London, UK; 1985.
21. Sobrinho ACN, de Souza EB, Fontenelle ROS. A review on antimicrobial potential of species of the genus Vernonia (Asteraceae). Journal of Medicinal Plants Research. 2015; 9(31): 838-850.
22. Builders MI. In search of a potent antimalarial agent: Antiplasmodial assessment of three herbs with folkloric antimalarial claims. International Journal of Biomedical and Clinical Sciences. 2018; 3(3): 40-46.
23. Kunle OF, Egharevba HO. Preliminary studies on Vernonia ambigua: Phytochemical and antimicrobial screening of the whole plant. Ethnobotanical Leaflets. 2009; 13: 1216–1221.
24. Aliyu B. Phytochemistry and quorum sensing inhibitory studies of four Vernonia species growing in Nigeria. PhD Thesis, University of KwaZulu-Natal, Durban, South Africa; 2017.
25. Okafo SE, Anie CO, Nwanua MC. Formulation and evaluation of antimicrobial topical creams from ethanol extract of Vernonia ambigua leaves. Nigeria Journal of Pharmaceutical Research. 2019, 15 (2) pp 249 – 255.
26. Kunle OF, Egharevba HO, Ibrahim J, Iliya I, Abdullahi MS, Okwute SK, Okogun JI. Antimicrobial activity of the extract of Vernonia ambigua (aerial part). Researcher. 2010; 2(6): 74-80.
27. Aliyu AB, Musa AM, Abdullahi MS, Ibrahim H, Oyewale OA. Phytochemical screening and antibacterial activities of Vernonia ambigua, Vernonia blumeoides, Vernonia oocephala (Asteraceae). Acta Poloniae Pharmaceutica Drug Research. 2011; 68: 67–73.
28. Ilondu EM. Fungitoxic activity of leaf extracts from four Asteraceae against Sclerotium rolfsil Sacc., an isolate of sweet potato (Ipomoea batatas (L) Lam) vine rot disease. Journal of Agricultural and Biological Sciences. 2012; 3(2): 287-295.
29. Ilondu EM. Phytochemical composition and efficacy of ethanolic leaf extracts of some Vernonia species against two phytopathogenic fungi. Journal of Biopesticides. 2013; 6(2): 165-172.
30. Omoigui ID, Aromose OSA. Nature of ergastic substances in some Nigerian Asteraceae. Bayero Journal of Pure and Applied Sciences. 2012; 5(2): 160–167.
31. Bhowmik D, Pankaj C, Tripathi KK, Chandira MR, Kumar KPS. Zingiber officinale the herbal and traditional medicine and its therapeutically importance. Research Journal of Pharmacognosy and Phytochemistry. 2010; 2(2): 102-110.
32. Singh UP, Parthasarathy R. Comparative pharmacognostical, preliminary phytochemical and acute toxicological evaluation of Blumea lacera var lacera and Blumea eriantha DC. Research Journal of Pharmacy and Technology. 2012; 5(6): 834-841.
33. Sahu L, Roy A, Satapathy T. A phytopharmacological review on Lawsonia inermis L. Research Journal of Science and Technology. 2012; 4(3): 93-107.
34. Mukhtar HM, Singh M, Vashishth D, Singh S, Kaur H. Standardization of the dried aerial parts of Bidens pilosa. Research Journal of Pharmacognosy and Phytochemistry. 2013; 5(2): 84-86.
35. Mital NM, Desai TR. In vitro anti-inflammatory and anti-Arthritic activities of fruits of Vernonia anthelmintica Willd. (Asteraceae). Asian Journal of Pharmaceutical Research. 4(4): 186-188.
36. Bhatt DY, Pandya SS. Pharmacognostic and preliminary phytochemical studies on the leaf of Beta vulgaris Linn. (Chenopodiaceae). Research Journal of Pharmacognosy and Phytochemistry. 2015; 7(3): 163-166.
37. Tiwari VJ. Validity of ethnopharmacological uses of Vicoa indica (L.) DC., family – Asteraceae. Research Journal of Pharmacognosy and Phytochemistry. 2018; 10(3): 207-210.
38. Gopalasatheeskumar K, Ariharasiva KG, Sengottuvel T, Sanish DV, Srividhya V. Quantification of total phenolic and flavonoid content in leaves of Cucumis melo var agrestis using UV- spectrophotometer. Asian Journal of Research Chemistry. 2019; 12(6): 335-337.
39. Taheri F, Abbaszadeh S, Valibeik A, Sattari E, Gholami E. The most important natural antioxidants and native herbs of Iran used in the nervous system as pre-anesthetics. Research Journal of Pharmacy and Technology. 2019; 12(3): 1453-1456.
40. Rohini KC, Rajesh CY. A review on phytopharmacological profile of traditionally used medicinal plant Parkia biglandulosa (Mimosaceae). Asian Journal of Pharmaceutical Research. 2020; 10(1): 34-38.
41. Aliyu AB, Oshanimi JA, Sulaiman MM, Gwarzo US, Garba ZN, Oyewale AO. Heavy metals and mineral elements of Vernonia ambigua, Vernonia oocephala and Vernonia pupurea used in northern Nigerian traditional medicine. Vitae. 2015; 22(1): 27-32.
42. Akinwande AA, Ogunshakin RY, Krishnamurthy R. Non specific immune response in the African catfish, Heterobranchus longifilis fed diets fortified with ethanolic extracts of selected traditional medicinal plants and disease resistance against Pseudomonas aeruginosa. Journal of Agricultural Research and Development. 2016; 15(1): 9-23.
43. Orji OU, Ibiam UA, Aja PM, Uraku AJ, Inya-Agha OR, Ugwu OPC. Hepatoprotective activity of ethanol extract of Vernonia ambigua against carbon tetrachloride induced hepatotoxicity in albino rats. IOSR Journal of Dental and Medical Sciences. 2015; 14(9): 22-29.
Received on 18.03.2020 Modified on 03.05.2020
Accepted on 15.06.2020 © RJPT All right reserved
Research J. Pharm. and Tech. 2020; 13(10):4715-4719.
DOI: 10.5958/0974-360X.2020.00830.6